Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
Sellas Life Sciences Group
Sellas Life Sciences Group
Gary Onik MD
National Institutes of Health Clinical Center (CC)
George Washington University
Duke University
University of Rochester
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Immatics Biotechnologies GmbH